JP2022503961A5 - - Google Patents
Info
- Publication number
- JP2022503961A5 JP2022503961A5 JP2021517801A JP2021517801A JP2022503961A5 JP 2022503961 A5 JP2022503961 A5 JP 2022503961A5 JP 2021517801 A JP2021517801 A JP 2021517801A JP 2021517801 A JP2021517801 A JP 2021517801A JP 2022503961 A5 JP2022503961 A5 JP 2022503961A5
- Authority
- JP
- Japan
- Prior art keywords
- substitution
- seq
- positions
- binding molecule
- heavy chain
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018010828 | 2018-09-28 | ||
| CNPCT/CN2018/010828 | 2018-09-28 | ||
| PCT/IB2019/001135 WO2020065409A2 (en) | 2018-09-28 | 2019-09-27 | Anti-cd40 binding molecules having engineered fc domains and therapeutic uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022503961A JP2022503961A (ja) | 2022-01-12 |
| JP2022503961A5 true JP2022503961A5 (https=) | 2022-10-04 |
| JPWO2020065409A5 JPWO2020065409A5 (https=) | 2022-10-04 |
| JP7626698B2 JP7626698B2 (ja) | 2025-02-04 |
Family
ID=69950020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517801A Active JP7626698B2 (ja) | 2018-09-28 | 2019-09-27 | 操作されたＦｃドメインを有する抗ＣＤ４０結合分子およびその治療用途 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP7626698B2 (https=) |
| AU (1) | AU2019349874A1 (https=) |
| CA (1) | CA3114567A1 (https=) |
| WO (1) | WO2020065409A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112512572B (zh) | 2018-04-20 | 2024-12-10 | 礼进生物医药科技（上海）有限公司 | 抗cd40抗体及其用途 |
| CR20230119A (es) * | 2020-08-07 | 2023-05-16 | Genentech Inc | Proteínas de fusión del ligando para flt3 y métodos de uso |
| JP2024500945A (ja) * | 2020-12-23 | 2024-01-10 | マクファーレン バーネット インスティテュート フォー メディカル リサーチ アンド パブリック ヘルス リミテッド | ＦｃガンマＲＩＩｂに対する親和性を有する修飾免疫グロブリン及びその使用方法 |
| WO2024126289A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection |
| WO2024126294A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection |
| WO2024126293A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US6265150B1 (en) | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| US20050136055A1 (en) * | 2003-12-22 | 2005-06-23 | Pfizer Inc | CD40 antibody formulation and methods |
| BRPI0417266B8 (pt) * | 2003-12-25 | 2021-05-25 | Kyowa Hakko Kirin Co Ltd | anticorpo monoclonal, seu uso e composição farmacêutica |
| EP2125893A2 (en) * | 2007-01-23 | 2009-12-02 | Xencor, Inc. | Optimized cd40 antibodies and methods of using the same |
| GB201115280D0 (en) * | 2011-09-05 | 2011-10-19 | Alligator Bioscience Ab | Antibodies, uses and methods |
| WO2016177771A1 (en) * | 2015-05-04 | 2016-11-10 | Apogenix Ag | Single-chain cd40-receptor agonist proteins |
| JP7497953B2 (ja) * | 2015-06-12 | 2024-06-11 | アレクトル エルエルシー | 抗ｃｄ３３抗体及びその使用方法 |
| AU2016285920A1 (en) * | 2015-06-29 | 2018-02-01 | Bristol-Myers Squibb Company | Antibodies to CD40 with enhanced agonist activity |
| ES2985566T3 (es) * | 2016-03-04 | 2024-11-06 | Univ Rockefeller | Anticuerpos contra CD40 con actividad agonista mejorada |
-
2019
- 2019-09-27 JP JP2021517801A patent/JP7626698B2/ja active Active
- 2019-09-27 CA CA3114567A patent/CA3114567A1/en active Pending
- 2019-09-27 WO PCT/IB2019/001135 patent/WO2020065409A2/en not_active Ceased
- 2019-09-27 AU AU2019349874A patent/AU2019349874A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022503961A5 (https=) | ||
| JP7809372B2 (ja) | アゴニスト抗体の活性を増強する抗体重鎖定常領域配列 | |
| JP7612596B2 (ja) | Ｅｎｐｐ３およびｃｄ３に結合するヘテロ二量体抗体 | |
| CN105246914B (zh) | Fc区变体 | |
| US20200231707A1 (en) | Readily isolated bispecific antibodies with native immunoglobulin format | |
| JP2019500892A5 (https=) | ||
| JP2019500891A5 (https=) | ||
| JP2018517401A5 (https=) | ||
| JP2020500540A5 (https=) | ||
| JP2020534351A5 (https=) | ||
| JP2013505732A (ja) | 二重特異性デス受容体アゴニスト抗体 | |
| JP2014523408A5 (https=) | ||
| JPWO2019226973A5 (https=) | ||
| US20230052369A1 (en) | Antibody constructs binding 4-1bb and tumor-associated antigens and uses thereof | |
| CA3130628A1 (en) | Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders | |
| TWI900702B (zh) | 多特異性抗原結合蛋白 | |
| JP2020502233A5 (https=) | ||
| JPWO2021019389A5 (https=) | ||
| JP7836088B2 (ja) | ＦｃγＲＩＩＢ親和性が増強された抗体Ｆｃ領域 | |
| JPWO2020065409A5 (https=) | ||
| CA3146977A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof | |
| JPWO2022212876A5 (https=) | ||
| JPWO2021181366A5 (https=) | ||
| US20250154287A1 (en) | ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF | |
| WO2024022495A1 (en) | Anti-MerTK ANTIBODIES AND USES THEREOF |